A service of arranging or bringing about contact between an investment manager and an issuer or potential issuer.
ENGLEWOOD, CO / March 11, 2020 / Aytu BioScience, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs, today announced that it has entered into a definitive agreement with a single...
Company Expects to Pursue Commercial Use Under FDA's Emergency Use Authorization ENGLEWOOD, CO / March 10, 2020 / Aytu BioScience, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs...
Aytu BioScience Enters Consumer Healthcare Market with a Portfolio of Over 35 Products that Generated $24M in Revenue During Past Four Quarters Combination Creates Specialty Rx and Consumer Pharma Company with LTM Revenue of Approximately $43M ENGLEWOOD, CO & SAN...
ENGLEWOOD, CO / February 13, 2020 / Aytu BioScience, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company focused on commercializing novel products that address significant medical needs, today will provide an overview of its business, including the company's...
ENGLEWOOD, CO / February 6, 2020 / Aytu BioScience, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs, today announced that the company will present its operational results for the...
ENGLEWOOD, CO / February 5, 2020 / Aytu BioScience, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs, today announced the acceptance of scientific abstracts reporting the findings...
ENGLEWOOD, CO / January 28, 2020 / Aytu BioScience, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs today announced the acceptance of a scientific abstract reporting the results of...
Aytu and Innovus Shareholder Meetings to Approve Merger Scheduled for February 13, 2020 ENGLEWOOD, CO & SAN DIEGO, CA / January 27, 2020 / Aytu BioScience, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company focused on commercializing novel products that...
ENGLEWOOD, CO and SAN DIEGO, CA / December 24, 2019 / Aytu BioScience, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs and Innovus Pharmaceuticals, Inc. (OTCQB:INNV), a specialty...
ENGLEWOOD, CO / December 5, 2019 / Aytu BioScience, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs, announced that MiOXSYS® will be featured in a Product Symposium at the 8th...